Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 4/20 | 0.49 |
| ▸ | ADH1C | P00326 | 3/20 | 0.49 |
| ▸ | ADH4 | P08319 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | SRD5A1 | P18405 | 3/20 | 0.30 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.30 |
| ▸ | HSD17B7 | P56937 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7517488 | 0.90 | ADH1A (0.39) | ADH1AADH1CADH4ALDH1A1ALOX15 | |
| SCHEMBL4408989 | 0.90 | ADH1A (0.50) | ADH1AADH1CADH4ALDH1A1ALOX15 | |
| SCHEMBL13508246 | 0.85 | ADH1A (0.50) | ADH1AADH1CADH4SRD5A1SRD5A2 | |
| SCHEMBL1276729 | 0.85 | ADH1A (0.50) | ADH1AADH1CADH4SRD5A1SRD5A2 | |
| SCHEMBL6341384 | 0.81 | ADH1A (0.50) | ADH1AADH1CADH4 | |
| SCHEMBL4093337 | 0.80 | ADH1A (0.61) | ADH1AADH1CADH4SRD5A1SRD5A2 | |
| SCHEMBL3836879 | 0.80 | ADH1A (0.61) | ADH1AADH1CADH4SRD5A1SRD5A2 | |
| SCHEMBL4096213 | 0.80 | ADH1A (0.61) | ADH1AADH1CADH4SRD5A1SRD5A2 | |
| SCHEMBL25701911 | 0.78 | ADH1A (0.44) | ADH1AADH1CADH4 | |
| SCHEMBL7514818 | 0.78 | ADH1A (0.39) | ADH1AADH1CADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6835288-B1 | Distillation; electron spin resonance; comprises 1-oxyl-2,2,6,6-tetramethylpiperidine as stabilizer | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-28 | — | — | US | claimed |
| EP-0815082-B1 | 4-ACYLAMINO PIPERIDIN-N-OXYLS | BASF AG (DE) | 2002-01-16 | — | — | EP | claimed |
| US-6268441-B1 | FORMING A VINYL CHLORIDE POLYMER IN THE PRESENCE OF N-OXYL COMPOUND OF SECONDARY AMINE WITH NO HYDROGENS ON ALPHA CARBONS AS ANTIDEPOSIT AGENTS ON REACTORS | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-31 | — | — | US | claimed |
| EP-0941254-B1 | METHOD FOR POLYMERIZING VINYL MONOMERS | BASF AG (DE) | 2000-06-28 | — | — | EP | claimed |
| US-5922244-A | NOVEL COMPOUNDS FOR STABILIZING ORGANIC MATERIALS AGAINST FREE RADICALS, PARTICULARLY IN THE DISTILLATION OF MONOMERS SUCH AS STYRENE | BASF AKTIENGESELLSCHAFT (DE) | 1999-07-13 | — | — | US | claimed |
| WO-1996029311-A1 | 4-ACYLAMINO PIPERIDIN-N-OXYLS | BASF AKTIENGESELLSCHAFT (DE) | 1996-09-26 | — | — | WO | claimed |
| EP-4419580-B1 | METHOD FOR PROMOTING HYDROSILYLATION REACTION TO PREPARE ESTER-FUNCTIONAL SILOXANE OLIGOMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12398270-B2 | Acrylate-functional branched organosilicon compound, method of preparing same, and copolymer formed therewith | DOW SILICONES CORPORATION (US) | 2025-08-26 | — | — | US | disclosed |
| US-12378264-B2 | Multifunctional organosilicon compound and related methods, compounds, and compositions | DOW SILICONES CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| US-12371535-B2 | Branched organosilicon compound, method of preparing same, and copolymer formed therewith | DOW SILICONES CORPORATION (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4172165-B1 | PREPARATION OF MULTIFUNCTIONAL ORGANOSILICON COMPOUNDS | DOW SILICONES CORP (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20250136763-A1 | SILICONE - VINYLESTER FUNCTIONAL COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN PERSONAL CARE COMPOSITIONS | DOW SILICONES CORP (US) | 2025-05-01 | — | — | US | disclosed |
| EP-4530323-A1 | CURABLE COMPOSITION FOR INKJET FOR METAL-CONTAINING BASE MATERIAL, SOLDER RESIST, AND INKJET RECORDING METHOD | KONICA MINOLTA, INC. (JP) | 2025-04-02 | — | — | EP | disclosed |
| EP-1077245-A2 | Inhibitor composition for stabilising radically polymerisable substances | BASF AKTIENGESELLSCHAFT (DE) | 2001-02-21 | — | — | EP | disclosed |
| WO-2000076943-A1 | METHOD FOR PREVENTING UNDESIRED POLYMERISATION IN A MIXTURE OF SUBSTANCES CONTAINING ETHYLENICALLY UNSATURATED COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2000-12-21 | — | — | WO | disclosed |
| US-6147145-A | VINYL MONOMERS IN WHICH THE VINYL BEARS A HETEROATOM SELECTED FROM NITROGEN, OXYGEN, SULFUR AND SILICON AND N-OXYL COMPOUND OF A SECONDARY AMINE WHICH DOES NOT BEAR HYDROGEN ON THE ALPH-CARBONS TO PREVENT PREMATURE POLYMERIZATION | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-14 | — | — | US | disclosed |
| US-6143205-A | A MIXTRUE COMPRISES A VINYL-CONTAINING MONOMERS, AND A MIXTURE OF PREMATURE POLYMERIZATION INHIBITOR OF MONOMERS DURING PURIFICATION OR DISTILLATION COMPRISING A N-OXYL COMPOUND OF SECONDARY AMINE AND A NITRO COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-07 | — | — | US | disclosed |
| EP-0941254-B1 | METHOD FOR POLYMERIZING VINYL MONOMERS | BASF AG (DE) | 2000-06-28 | — | — | EP | disclosed |
| EP-0941254-A1 | METHOD FOR POLYMERIZING VINYL MONOMERS | BASF AKTIENGESELLSCHAFT (DE) | 1999-09-15 | — | — | EP | disclosed |
| WO-1998023649-A1 | METHOD FOR POLYMERIZING VINYL MONOMERS | BASF AKTIENGESELLSCHAFT (DE) | 1998-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378264-B2 | Multifunctional organosilicon compound and related methods, compounds, and compositions | MSR1, OXSR1, RIOX2 | ADH1A 2135/4885ADH1C 2379/4885ADH4 4067/4885 |
| US-20250136763-A1 | SILICONE - VINYLESTER FUNCTIONAL COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN PERSONAL CARE COMPOSITIONS | VCL, FANCF, MMS19 | ADH1A 510/4885ADH1C 425/4885ADH4 456/4885 |
| US-12371535-B2 | Branched organosilicon compound, method of preparing same, and copolymer formed therewith | OXSR1, BRS3, OXER1 | ADH1A 2907/4885ADH1C 2522/4885ADH4 2116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.